Finally, Yoriki et al. [27] presented a 43-year-old patient with stage IIIB disease carrying a germline BRCA2 mutation who also had concurrent ductal carcinoma in situ (breast). The gene discussed is BRCA2; the disease is ductal breast carcinoma in situ.